CelltextT is a minimally manipulated Wharton's Jelly derived human tissue allograft. Rich in cytokines, growth factors, and proteins. CelltextT is for homologous use and is processed to preserve the structural integrity of the Wharton's Jelly.
Advantages of CelltextT™
CelltextT product is less invasive than adipose tissue extraction and bone marrow aspiration resulting in shorter procedure times and more importantly, less pain.
CelltextT does not use any material obtained directly from the embryo or fetus with higher concentrations of peptides, hyaluronic acid and growth factors compared to amniotic fluid suspensions. Due to the high concentrations of growth factors in the Umbilical Cord Matrix also known as Wharton's Jelly, it acts as an ideal anti-inflammatory and has been shown in clinical studies to prevent apoptosis.
CelltextT is processed from donated human tissue from full term, c-section deliveries in accordance with the FDA. CelltextT is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.
Common Areas of Treatment
- Fortify PRP Procedures
- Muscular Tears
- Plantar Fasciitis
- Bone Spurs
- Rotator Cuff Tears
- Persistent Partial Tendon Tears
- Quadriceps and Patellar Tendon Tears
- Meniscus and Cartilage Tears
- Radicular and Sacroiliac Nerves and Pinched Nerves
- Large joints such as the Hip, Shoulder, Knee